Infinity Mining Limited (ASX:IMI)

CTI BioPharma Balance Sheet

Financials in millions AUD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	0.6	0.25	3.32	8.24	0.01
Cash & Short-Term Investments	0.6	0.25	3.32	8.24	0.01
Cash Growth	139.02%	-92.45%	-59.64%	124382.95%	5.52%
Accounts Receivable	-	-	0.02	-	-
Other Receivables	0.04	0.09	0.19	0.08	0.01
Receivables	0.04	0.09	0.21	0.08	0.01
Prepaid Expenses	-	-	0.05	0.1	-
Other Current Assets	0.05	0	-	-	-
Total Current Assets	0.69	0.34	3.59	8.41	0.01
Property, Plant & Equipment	5.55	8.14	12.99	9.25	0.08
Total Assets	6.24	8.47	16.57	17.66	0.1
Accounts Payable	0.06	0.17	0.33	0.14	0.07
Accrued Expenses	0.03	-	0.16	-	-
Other Current Liabilities	0.09	0.11	0.05	-	0
Total Current Liabilities	0.18	0.28	0.54	0.14	0.07
Long-Term Debt	0.23	0.32	-	0.05	0.3
Total Liabilities	0.41	0.6	0.54	0.19	0.37
Common Stock	26.8	20.95	20.35	19.62	0.49
Retained Earnings	-21.09	-13.3	-4.57	-2.84	-0.77
Comprehensive Income & Other	0.13	0.23	0.26	0.69	-
Shareholders' Equity	5.83	7.87	16.04	17.47	-0.28
Total Liabilities & Equity	6.24	8.47	16.57	17.66	0.1
Total Debt	0.23	0.32	-	0.05	0.3
Net Cash (Debt)	0.37	-0.07	3.32	8.19	-0.3
Net Cash Growth	-	-	-59.41%	-	-
Net Cash Per Share	0.00	-0.00	0.03	0.08	-0.61
Filing Date Shares Outstanding	420.84	118.75	112.62	108.81	0.49
Total Common Shares Outstanding	423.02	118.75	112.62	108.81	0.49
Working Capital	0.51	0.06	3.05	8.27	-0.05
Book Value Per Share	0.01	0.07	0.14	0.16	-0.57
Tangible Book Value	5.83	7.87	16.04	17.47	-0.28
Tangible Book Value Per Share	0.01	0.07	0.14	0.16	-0.57
Machinery	0.08	0.21	0.21	0.01	0

Updated Dec 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.